Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

US, India, China Account For 60% Of 2 Billion Vaccine Doses Distributed Globally: WHO

US, India, China Account For 60% Of 2 Billion Vaccine Doses Distributed Globally: WHO

Senior Advisor to WHO Director-General Tedros Adhanom Ghebreyesus, Bruce Aylward made the comments at a press briefing on Friday.
Of the two billion COVID-19 vaccine doses distributed globally till now, about 60 per cent have gone to just three countries - the US, India and China, a senior adviser at the World Health Organisation said.

Senior Advisor to WHO Director-General Tedros Adhanom Ghebreyesus, Bruce Aylward made the comments at a press briefing on Friday.

This week, we will see over two billion doses we will probably pass the two billion doses landmark in terms of the number of doses of the vaccines and new COVID-19 vaccines that have actually been developed. These have been distributed now in over 212 countries, Aylward said.

If we look at that two billion doses, over 75 per cent of it has gone to just 10 countries. And in fact three countries - China, the US and India - account for about 60 per cent of those doses, he said.

He said while COVAX has played an important role in distributing the COVID-19 doses to 127 countries and getting several countries to start their vaccination drives, the challenge is in the access to the vaccines.

He said the 60 per cent of the two billion doses that have gone to China, India and the US are all domestically procured and used .

Aylward noted that at the other end of the spectrum , only about 0.5 per cent of doses globally have gone to the lowest income countries that account for about 10 per cent of the world's population.

And even if we look at the lower middle income countries, it's only fractionally higher than that in terms of the coverage that we're getting. So we're increasingly seeing a two-track recovery and rollout of the vaccines, he said.

While there is high vaccine coverage deep into the high risk populations and younger populations in high income countries, we are still struggling to get sufficient product just to be able to vaccinate the health care workers, older populations in low income countries who are really the key to getting out of the health, societal and economic crisis that we are in the midst of.

Aylward said about 80 million doses have been distributed through COVAX so far and the global alliance for equitable vaccine distribution is about 200 million doses behind where it should be due to the disruption in COVAX supplies as a result of the devastating second wave in India.

The problem now is the supplies are being interrupted. We're having disruptions because of the problems in India and others and having trouble filling that gap. And as a result, the countries are having trouble getting momentum and getting started well.

"We saw how long it took to get the scale up of vaccines in high income countries. It takes a consistent supply of vaccines. So this is the crucial piece that we've got to fix in the next two months if we are going to be on track to get out of the pandemic," Aylward said.

He added that through COVAX, we've distributed just about 80 million doses at this point. We're about 200 million doses behind where we want to be because of the interruption of supply out of India because of the need to redirect them there. And also because of the challenge that we're having getting other manufacturers to scale up and come online early enough, such as the Johnson and Johnson product.

He said while there are commitments in principle of about 150 million doses to be donated through COVAX, there are two big problems with that.

Number one, very little of it is committed for the June-July period, which means we're going to still have this gap. The other problem is just the volume. If we are going to get on track to get at least 30-40 per cent of the world vaccinated this year, we got to get another 250 million people vaccinated between now and the end of September.

We expect India SII (Serum Institute of India) volumes to open up again in the fourth quarter at least, he said, adding that countries are going to fail unless they get vaccines early to start rolling out, building community confidence, building their systems. But we're setting up for failure if we don't get early doses.

The Serum Institute of India (SII), the world's largest vaccine manufacturer, is the key supplier of AstraZeneca doses to COVAX. However, supply of vaccines from SII to COVAX has been impacted as the second wave of the COVID-19 pandemic ravages India.

Last month, Ghebreyesus had said that once the devastating outbreak in India recedes, we also need the Serum Institute of India to get back on track and catch up on its delivery commitments to COVAX.

In response to a question on the situation in India and Nepal, which are seeing devastating surges in COVID-19 cases, he said, are we concerned about India and Nepal. Absolutely. We've got escalating epidemics in different parts of India still. (It's) going down overall but some areas are still hard hit.

In Nepal too, areas are hard hit. Still real gaps in terms of what they need to be able to save lives in real time, as well as protect people with vaccines so as we look for doses and bringing the doses forward, the goal is to be able to get more doses surged into these places that are being hit, so that we can reduce the risk of death in the face of these escalating outbreaks as well.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×